A systematic review of dalbavancin efficacy as a sequential therapy for infective endocarditis
GM Leanza, E Rando, F Frondizi, E Taddei… - Infection, 2024 - Springer
Introduction Dalbavancin is an antibiotic characterized by an extended half-life and efficacy
against methicillin-resistant Staphylococci. Currently, there are only narrative reviews …
against methicillin-resistant Staphylococci. Currently, there are only narrative reviews …
Dalbavancin plasma concentrations in 133 patients: a PK/PD observational study
C Hervochon, B Hennart, AG Leroy… - Journal of …, 2023 - academic.oup.com
Objectives Limited pharmacokinetics data support dalbavancin long-term use in off-label
indications and the optimal dosing regimen is debated. We aimed to describe dalbavancin …
indications and the optimal dosing regimen is debated. We aimed to describe dalbavancin …
[HTML][HTML] Dalbavancin as consolidation therapy for infective endocarditis in patients with comorbidity. A real world experience
D Brandariz-Núñez, A Luances-Rodríguez… - Revista Española de …, 2024 - ncbi.nlm.nih.gov
Results: Forty-eight patients were included, 58.3% were male, mean age of 76.2 years (IQR:
66-88), and a mean age adjusted CCI of 6.5 (IQR: 5-7.5). Definite IE was diagnosed in 77 …
66-88), and a mean age adjusted CCI of 6.5 (IQR: 5-7.5). Definite IE was diagnosed in 77 …
[引用][C] Side effects of miscellaneous antibiotics
E Samuel, JD McCanless, Z Saadut, A Wilson, K Bhut… - 2024 - Elsevier